within Pharmacolibrary.Drugs.R_RespiratorySystem.R05D_CoughSuppressantsExclCombinationsWithExpectorant.R05DB27_Levodropropizine;

model Levodropropizine
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_1C_enteral(
    weight = 70,
    F = 0.75,
    Cl = 1.2833333333333335e-06,
    adminDuration = 600,
    adminMass = 60 / 1000000,
    adminCount = 1,
    Vd = 0.0007,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    ka = 0.005666666666666667,
    Tlag = 600);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Levodropropizine</td></tr><tr><td>ATC code:</td><td>R05DB27</td></tr><td>route:</td><td>oral</td></tr>
    <tr><td>compartments:</td><td>1</td></tr>
    <tr><td>dosage:</td><td>60</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>0.7</td><td>L</td></tr>
    <tr><td>clearance:</td><td>0.066</td><td>L/h/kg</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Levodropropizine is a non-opioid antitussive drug used for the symptomatic treatment of cough. It acts as a peripheral cough suppressant and is available in many countries over-the-counter or as prescription medication, but is not approved by the US FDA.</p><h4>Pharmacokinetics</h4><p>Healthy adult volunteers, after oral administration of levodropropizine. Pharmacokinetic parameters estimated from population PK study.</p><h4>References</h4><ol><li><p>Jang, JW, et al., &amp; Lee, KT (2013). Relative bioavailability of levodropropizine 60 mg capsule and syrup formulations in healthy male Korean volunteers: a singledose, randomized-sequence, open-label, two-way crossover study. <i>International journal of clinical pharmacology and therapeutics</i> 51(2) 152–160. DOI:<a href=\"https://doi.org/10.5414/cp201730\">10.5414/cp201730</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/23351597/\">https://pubmed.ncbi.nlm.nih.gov/23351597</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.R.R05DB27 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Levodropropizine;
